Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Entrada Therapeutics Inc
NASDAQ:TRDA
Entrada Therapeutics Inc
NASDAQ:TRDA
Price:
5.09
USD
-1.55%
Market Closed
Market Cap:
$198.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
TRDA Price Forecast
Based on 7 analysts
Based on 7 analysts
+361% Upside
from
$5.09
today
Entrada Therapeutics Inc (TRDA)’s 12-month stock price forecast through November 2027 has a consensus target of $23.46, implying 361% upside. The forecast is based on price targets from 7 Wall Street analysts.
TRDA Analyst Rating
Based on 7 analysts
Based on 7 analysts
Analysts rate TRDA Strong buy, with 6 of 7 recommending Buy or Strong buy.
Entrada Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRDA's stock price target?
Price Target
23.46
USD
23.46
USD
According to Wall Street analysts, the average 1-year price target for TRDA is 23.46 USD with a low forecast of 10.1 USD and a high forecast of 28.35 USD.
What is the Revenue forecast for Entrada Therapeutics Inc?
Projected CAGR
45%
45%
The compound annual growth rate for Revenue over the next 8 years is 45%.
